Medicus Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	9.67	4.16	1.72	0.27	0.08
Cash & Short-Term Investments	9.67	4.16	1.72	0.27	0.08
Cash Growth	228.99%	142.21%	542.38%	240.90%	-
Prepaid Expenses	0.95	1.21	0.17	0.02	-
Total Current Assets	11	5.38	1.89	0.28	0.08
Property, Plant & Equipment	0.22	0.27	-	-	-
Total Assets	11.93	5.65	1.89	0.28	0.08
Accounts Payable	1.77	1.28	0.21	0.1	0.16
Accrued Expenses	1.83	0.76	0.4	-	-
Short-Term Debt	4.82	0.14	0.17	1.53	0.67
Current Portion of Leases	0.12	0.12	-	-	-
Other Current Liabilities	-	-	-	10.85	9.75
Total Current Liabilities	8.54	2.31	0.78	12.48	10.58
Long-Term Leases	0.14	0.21	-	-	-
Total Liabilities	8.69	2.51	0.78	12.48	10.58
Common Stock	37.83	30.52	18.76	0.19	0.19
Additional Paid-In Capital	5.6	1.52	0.1	-	-
Retained Earnings	-40.18	-28.9	-17.75	-12.39	-10.7
Shareholders' Equity	3.25	3.13	1.11	-12.2	-10.51
Total Liabilities & Equity	11.93	5.65	1.89	0.28	0.08
Total Debt	5.09	0.46	0.17	1.53	0.67
Net Cash (Debt)	4.58	3.7	1.55	-1.26	-0.59
Net Cash Growth	78.70%	138.16%	-	-	-
Net Cash Per Share	0.37	0.38	0.45	-0.67	-0.18
Filing Date Shares Outstanding	15.94	11.82	8.08	6.43	3.22
Total Common Shares Outstanding	15.94	11.82	8.08	6.43	3.22
Working Capital	2.45	3.07	1.11	-12.2	-10.51
Book Value Per Share	0.20	0.27	0.14	-1.90	-3.27
Tangible Book Value	3.25	3.13	1.11	-12.2	-10.51
Tangible Book Value Per Share	0.20	0.27	0.14	-1.90	-3.27

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q